D-0814-2021 Class II
FDA drug recall D-0814-2021 was initiated by Morton Grove Pharmaceuticals, Inc. on Sep 3, 2021 and is designated Class II. Reason for recall: CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms. Affected quantity: 116,400 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 29, 2021
- Initiation Date
- Sep 3, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 116,400 bottles
Product description
Promethazine Syrup Plain, 6.25 mg/5 mL (Promethazine Hydrochloride Syrup, USP), 1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054; Manuractured By: Morton Grove Pharmaceuticals, Inc, Morton Grove, IL 60053. NDC: 60432-608-16
Reason for recall
CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
Distribution pattern
Nationwide USA and China
Code information
Lot #: UV1335; UV1352; and UV1373
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0814-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026